Lysophosphatidylinositol
Lysophosphatidylinositol (LPI) is a bioactive lipid that acts as a secondary messenger in the cell signaling process. It is a member of the lysophospholipid (LPL) family, which are lipids that have been modified by the addition of a phosphate group. LPI plays a crucial role in various biological processes, including cell proliferation, differentiation, and survival.
Structure
Lysophosphatidylinositol is composed of a glycerol backbone, a phosphate group, and a fatty acid chain. The glycerol backbone is linked to the phosphate group at the sn-3 position, and the fatty acid chain is attached to the glycerol backbone at the sn-1 position. This structure is what distinguishes LPI from other lysophospholipids, which have their fatty acid chains attached at the sn-2 position.
Function
Lysophosphatidylinositol functions as a signaling molecule in the body. It binds to the G protein-coupled receptor GPR55, which is involved in a variety of physiological processes, including pain perception, bone growth, and blood pressure regulation. LPI can also act as a ligand for other receptors, such as the cannabinoid receptor CB1 and CB2.
In addition to its role in cell signaling, LPI has been found to have other biological functions. For example, it can act as a mitogen, stimulating cell division and growth. It can also promote cell survival by inhibiting apoptosis, or programmed cell death.
Clinical significance
Abnormal levels of Lysophosphatidylinositol have been associated with various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. For example, elevated levels of LPI have been found in the blood of patients with ovarian cancer, suggesting that it may play a role in the development or progression of this disease. Similarly, decreased levels of LPI have been observed in the brains of patients with Alzheimer's disease, suggesting a potential role in neurodegeneration.
See also

This article is a biochemistry stub. You can help WikiMD by expanding it!
This article is a Cell biology-related stub. You can help WikiMD by expanding it!
```
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian